Koylanchal i9 Eye & Dental Centre

13/12/2025

13/12/2025

13/12/2025

........भारत के हिस्से तोड़ मरोड़कर...बांग्लादेश का दिखाने वाले....बांग्लादेश के छात्र नेता....उस्मान हादी को "अज्ञात" लोगों ने सिर मे गोली मार दी😁.....जयहिंद 🇮🇳🚩

13/12/2025

New Study (Aug 2025, Ophthalmology Science)
Retinal and Choroidal Microvasculature at Different Myopia Severities: A Systematic Review & Meta-Analysis

A comprehensive review of 47 studies (7,293 eyes) examined OCT-A–based microvascular changes across mild, moderate, and high myopia.

📊 Key Findings:
• High myopia:
• Enlarged foveal avascular zone (FAZ) (~20–30% larger vs controls).
• Reduced parafoveal vessel density in superficial plexus (~44% vs 48%, p

01/11/2024

01/11/2024

Physicists Synthesized the Element Livermorium, Atomic Number 116 — Opening the Door to Discovering Record-Breaking Elements:

Physicists at Lawrence Berkeley National Laboratory have synthesized livermorium (element 116) using a new method that could pave the way for creating superheavy elements beyond the limits of the current periodic table.

Traditionally, high-Z elements are made by bombarding actinide targets with calcium-48, a stable isotope.

However, this technique is reaching its limits. The research team, using the 88-Inch Cyclotron, successfully collided titanium-50 ions with a plutonium target over 22 days, marking the first time a non-calcium isotope has produced a superheavy element.

The breakthrough brings scientists closer to discovering new elements in the elusive "island of stability," where superheavy elements may exhibit longer half-lives.

Producing elements beyond oganesson (element 118) has been challenging due to low reaction probabilities, but this new approach offers hope.

With the potential to uncover 50 more unknown isotopes, researchers believe this method could unlock new discoveries and provide insights into the fundamental nature of atomic structure.

28/10/2024

Eye exercises that *may* help prevent or manage glaucoma:

*Important:* Consult an eye care professional before starting any new eye exercises, especially if you have existing glaucoma or eye conditions.

*Warm-up Exercises:*

1. Eye Rotation: Rotate eyes clockwise and counterclockwise (3 reps each).
2. Eye Movement: Move eyes up, down, left, and right (3 reps each).
3. Blinking: Blink rapidly (3 times) to improve tear circulation.

*Glaucoma-Specific Exercises:*

1. Acupressure: Apply gentle pressure to specific points around the eyes:
- Temple (Tai Chong): Massage with fingertips (1minute).
- Eye Socket (Jing Ming): Massage with fingertips (1 minute).
2. Eye Stretching: Look upward, then downward, stretching eye muscles (3 reps).
3. Focusing Exercise: Focus on a point, then suddenly shift gaze to another point (3 reps).
4. Near and Far Vision: Alternate between near and far objects (3 reps).
5. Eye Massage: Gently massage eyes with circular motions (1 minute).

*Yoga and Breathing Exercises:*

1. Pranayama (Breathing Exercise): Practice deep, controlled breathing.
2. Yoga Postures: Certain poses, such as:
- Downward-Facing Dog
- Child's Pose
- Seated Forward Fold

*Lifestyle Changes:*

1. Regular Exercise: Engage in moderate physical activity.
2. Balanced Diet: Include omega-3 rich foods, antioxidants, and vitamins.
3. Stress Management: Practice relaxation techniques (meditation, yoga).
4. Sleep: Ensure adequate sleep (7-8 hours) to reduce eye pressure.
5. Regular Eye Exams: Schedule *annual* eye exams to monitor eye health.

*Prevention Tips:*

1. Maintain healthy blood pressure.
2. Avoid smoking.
3. Limit caffeine intake.
4. Wear sunglasses with UV protection.
5. Avoid prolonged screen time.

*Resources:*

1. American Academy of Ophthalmology (AAO)
2. Glaucoma Research Foundation (GRF)
3. National Eye Institute (NEI)

Remember, while these exercises may be beneficial, they should not replace medical treatment or advice. Consult an eye care professional for personalized guidance.

13/10/2024

An oral insulin pill may soon be available for people with diabetes:

It would potentially replace painful injections for millions of people with diabetes.

This groundbreaking pill utilizes a nano-scale material, a fraction of the width of a human hair, to protect insulin molecules from stomach acid and deliver them precisely to where they are needed in the body.

The nanomaterial also acts as a "nano-carrier," responding to the patient's blood sugar levels. The nano-carrier is designed to dissolve and release insulin only when blood sugar levels are elevated, preventing the release when levels are low. This unique feature could reduce the risk of hypoglycemia, a dangerous condition caused by excessive insulin intake, which is a common concern for those relying on insulin injections. This oral insulin has been successfully tested on animals, demonstrating effective blood glucose control without toxicity.

Human trials are scheduled to start in 2025, potentially revolutionizing diabetes treatment. The potential impact of this oral insulin pill on the lives of millions of people with diabetes worldwide cannot be overstated. By replacing painful injections with a convenient oral medication, this innovation could significantly improve the quality of life for those living with this chronic condition. The intelligent release mechanism of the nano-carrier could lead to better blood glucose management and a reduced risk of hypoglycemia, ultimately contributing to improved health outcomes and a brighter future for individuals with diabetes.

13/10/2024

Posterior Microphthalmus/ Macular Fold:
Despite normal anterior segment, posterior microphthalmos is characterized with high hyperopia, shorter axial length and papillomacular retinal fold.
Credit: on photo.

12/10/2024

Scientists discovered an on/off switch that can "turn off" autoimmune disorders:

It stops your immune system from attacking healthy cells.

Our immune system protects us from harmful invaders, but sometimes it mistakenly attacks our own healthy cells, leading to autoimmune disorders.

Scientists have now identified a critical 'switch' that helps regulate the immune system and could be key to understanding and potentially treating these conditions. At the heart of this discovery is an enzyme called cGAS, which acts as a sensor for foreign DNA. When it detects a virus, it triggers an immune response. However, cGAS needs to be carefully controlled, particularly within a cell's nucleus where DNA is stored. The newly identified 'switch' involves a protein complex that flags cGAS for destruction, effectively turning it off when it's not needed. This prevents cGAS from attacking healthy cells during normal cell growth.

By understanding how proteins like cGAS are controlled, scientists hope to develop new treatments for autoimmune disorders, where the immune system mistakenly attacks the body's own tissues. The findings also suggest that targeting this 'switch' could offer potential therapeutic strategies. Autoimmune disorders occur when the body's immune system, designed to protect against foreign invaders like viruses and bacteria, malfunctions and mistakenly attacks healthy cells and tissues. This misdirected attack can cause inflammation, pain, and damage to various organs and systems. There are over 80 types of autoimmune disorders, including rheumatoid arthritis, lupus, type 1 diabetes, and multiple sclerosis, affecting millions of people worldwide.

12/10/2024

12/10/2024

The Science of Ozempic — Understanding the "Miracle" Weightloss Drug:

Ozempic, originally designed to manage type 2 diabetes, has exploded in popularity due to its weight loss effects.

Celebrities and social media influencers tout its rapid results, leading to increased demand for both Ozempic and its higher-dose weight-loss counterpart, Wegovy. Doctors prescribe Ozempic off-label for weight loss, and some individuals even seek it through less regulated online channels. Experts warn that Ozempic isn't a magic solution; its function is to regulate blood sugar, mimic fullness hormones, and slow digestion. While it aids weight loss in those with obesity and related conditions, it has not been thoroughly studied in people without those issues. The medication is intended for long-term use, and weight often returns upon discontinuation. The drug operates by increasing insulin production post-meal, slowing food movement through the stomach, and reducing sugar release into the bloodstream. Ozempic can be expensive, and insurance coverage often requires meeting specific FDA criteria. The surge in off-label use has contributed to shortages, making it difficult for diabetes patients to access it. Side effects are common, including nausea, digestive problems, and in rare cases, pancreatitis, highlighting the need for careful medical supervision while on the drug. Doctors caution that the long-term consequences of using this medication for weight loss in people who don't have diabetes or obesity are unknown, and there could be unforeseen health risks.